Correlation Between Mineralys Therapeutics, and Vodka Brands

Can any of the company-specific risk be diversified away by investing in both Mineralys Therapeutics, and Vodka Brands at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Mineralys Therapeutics, and Vodka Brands into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Mineralys Therapeutics, Common and Vodka Brands Corp, you can compare the effects of market volatilities on Mineralys Therapeutics, and Vodka Brands and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Mineralys Therapeutics, with a short position of Vodka Brands. Check out your portfolio center. Please also check ongoing floating volatility patterns of Mineralys Therapeutics, and Vodka Brands.

Diversification Opportunities for Mineralys Therapeutics, and Vodka Brands

-0.61

Correlation Coefficient

Mineralys Therapeutics,  Vodka Brands

Excellent diversification

The 3 months correlation between Mineralys and Vodka is -0.61. Overlapping area represents the amount of risk that can be diversified away by holding Mineralys Therapeutics, Common and Vodka Brands Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Vodka Brands Corp and Mineralys Therapeutics, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Mineralys Therapeutics, Common are associated (or correlated) with Vodka Brands. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Vodka Brands Corp has no effect on the direction of Mineralys Therapeutics, i.e., Mineralys Therapeutics, and Vodka Brands go up and down completely randomly.

Pair Corralation between Mineralys Therapeutics, and Vodka Brands

Given the investment horizon of 90 days Mineralys Therapeutics, Common is expected to generate 2.5 times more return on investment than Vodka Brands. However, Mineralys Therapeutics, is 2.5 times more volatile than Vodka Brands Corp. It trades about 0.1 of its potential returns per unit of risk. Vodka Brands Corp is currently generating about 0.05 per unit of risk. If you would invest  1,234  in Mineralys Therapeutics, Common on December 20, 2024 and sell it today you would earn a total of  441.00  from holding Mineralys Therapeutics, Common or generate 35.74% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Weak
Accuracy	96.77%
Values	Daily Returns

Mineralys Therapeutics, Common  vs.  Vodka Brands Corp

Mineralys Therapeutics,

Risk-Adjusted Performance

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Mineralys Therapeutics, Common are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively weak basic indicators, Mineralys Therapeutics, unveiled solid returns over the last few months and may actually be approaching a breakup point.

Vodka Brands Corp

Risk-Adjusted Performance

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Vodka Brands Corp are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak forward-looking signals, Vodka Brands may actually be approaching a critical reversion point that can send shares even higher in April 2025.

Pair Trading with Mineralys Therapeutics, and Vodka Brands

The main advantage of trading using opposite Mineralys Therapeutics, and Vodka Brands positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Mineralys Therapeutics, position performs unexpectedly, Vodka Brands can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Vodka Brands will offset losses from the drop in Vodka Brands' long position.

The idea behind Mineralys Therapeutics, Common and Vodka Brands Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.